Location: Boston, MA
CIK: 0001583977 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value: $1.449B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 17,878,594 | $207M | 14.3% | $11.58 | — | COM NEW | 107924102 |
| ABVX | ABIVAX SA | 1,950,000 | $166M | 11.4% | $10.70 | — | SPONSORED ADS | 00370M103 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 8,325,000 | $119M | 8.2% | $11.03 | +4.3% | COM NEW | 30233G209 |
| RAPP | RAPPORT THERAPEUTICS INC | 3,192,521 | $94.82M | 6.5% | $22.73 | -21.5% | COM | 75383L102 |
| BBIO | BRIDGEBIO PHARMA INC | 1,400,000 | $72.72M | 5.0% | $20.96 | +132.7% | COM | 10806X102 |
| EWTX | EDGEWISE THERAPEUTICS INC | 4,010,000 | $65.04M | 4.5% | $23.73 | -40.2% | COM | 28036F105 |
| DRUG | BRIGHT MINDS BIOSCIENCES INC | 1,059,331 | $64.26M | 4.4% | $35.19 | +10.3% | COM NEW | 10919W405 |
| ACLX | ARCELLX INC | 775,000 | $63.63M | 4.4% | $25.75 | +179.6% | COMMON STOCK | 03940C100 |
| INSM | INSMED INC | 430,000 | $61.92M | 4.3% | $37.15 | +229.8% | COM PAR $.01 | 457669307 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 2,175,000 | $61.86M | 4.3% | $20.31 | +18.0% | ORDINARY SHARES | N62509109 |
| PRAX | PRAXIS PRECISION MEDICINES I | 1,000,000 | $53M | 3.7% | $54.23 | -10.6% | COM NEW | 74006W207 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 1,925,000 | $46.68M | 3.2% | $13.13 | — | SPONSORED ADS | 152309100 |
| PHVS | PHARVARIS N V | 1,363,200 | $34.01M | 2.3% | $21.48 | +3.2% | COM | N69605108 |
| CRBP | CORBUS PHARMACEUTICALS HLDGS | 2,375,000 | $30.04M | 2.1% | $28.57 | -66.7% | COM NEW | 21833P301 |
| GHRS | GH RESEARCH PLC | 1,916,439 | $27.41M | 1.9% | $13.91 | +0.6% | ORDINARY SHARES | G3855L106 |
| CGON | CG ONCOLOGY INC | 625,000 | $25.18M | 1.7% | $39.73 | -26.8% | COM | 156944100 |
| KRRO | KORRO BIO INC | 465,000 | $22.27M | 1.5% | $26.87 | -17.4% | COM | 500946108 |
| MBX | MBX BIOSCIENCES INC | 1,225,000 | $21.44M | 1.5% | $18.80 | -28.9% | COM | 55287L101 |
| — | METSERA INC | 400,000 | $20.93M | 1.4% | $27.22 | — | COM | 59267L107 |
| JANX | JANUX THERAPEUTICS INC | 850,000 | $20.77M | 1.4% | $40.93 | -40.5% | COM | 47103J105 |
| TARS | TARSUS PHARMACEUTICALS INC | 300,000 | $17.83M | 1.2% | $21.36 | +130.5% | COM | 87650L103 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 400,000 | $16.66M | 1.1% | $24.75 | +29.2% | COM | 22663K107 |
| ENGN | ENGENE HOLDINGS INC | 2,323,595 | $15.87M | 1.1% | $9.69 | -52.9% | COM | 29286M105 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 775,000 | $14.61M | 1.0% | $7.71 | +104.5% | COM | 03969K108 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 1,994,173 | $14.3M | 1.0% | $12.22 | +326.5% | CLASS A ORD | 61559X104 |
| RNAM | AVIDITY BIOSCIENCES INC | 300,000 | $13.07M | 0.9% | $38.44 | +5.2% | COM | 05370A108 |
| BIOA | BIOAGE LABS INC | 2,140,605 | $12.59M | 0.9% | $18.97 | -75.3% | COM | 09077V100 |
| AXSM | AXSOME THERAPEUTICS INC | 100,000 | $12.14M | 0.8% | $74.04 | +52.1% | COM | 05464T104 |
| CABA | CABALETTA BIO INC | 5,000,000 | $11.7M | 0.8% | $1.56 | +10.0% | COM | 12674W109 |
| ORKA | ORUKA THERAPEUTICS INC | 533,340 | $10.26M | 0.7% | $14.82 | 0.0% | COM | 687604108 |
| ALMS | ALUMIS INC | 2,147,396 | $8.568M | 0.6% | $13.30 | -69.0% | COM | 022307102 |
| BMEA | BIOMEA FUSION INC | 3,570,872 | $7.213M | 0.5% | $17.07 | -89.3% | COM | 09077A106 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 500,000 | $6.795M | 0.5% | $9.41 | 0.0% | COM | 03237H101 |
| PCVX | VAXCYTE INC | 175,000 | $6.303M | 0.4% | $53.56 | -38.1% | COM | 92243G108 |
| ELVN | ENLIVEN THERAPEUTICS INC | 200,000 | $4.094M | 0.3% | $25.92 | -22.2% | COM | 29337E102 |
| BHVN | BIOHAVEN LTD | 10,000 | $150K | 0.0% | $43.60 | -66.6% | COM | G1110E107 |